Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 15166201)

1.

Commentary: the hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology?

Lawlor DA, Davey Smith G, Ebrahim S.

Int J Epidemiol. 2004 Jun;33(3):464-7. Epub 2004 May 27. No abstract available.

2.

Number needed to treat from absolute risk and incidence rate: how to make apples and oranges comparable?

Girerd N, Rabilloud M, Duarte K, Roy P.

J Clin Epidemiol. 2014 Feb;67(2):236-8. doi: 10.1016/j.jclinepi.2013.08.010. Epub 2013 Nov 7. No abstract available.

PMID:
24210846
3.

Estimation of numbers needed to treat should be based on absolute risks.

Bender R, Kromp M, Kiefer C, Sturtz S.

J Clin Epidemiol. 2014 Feb;67(2):238-9. doi: 10.1016/j.jclinepi.2013.08.009. Epub 2013 Oct 31. No abstract available.

PMID:
24183605
4.

Estimating population impact.

Glasgow RE.

Am J Prev Med. 2012 Mar;42(3):e30-1; author reply e31-2. doi: 10.1016/j.amepre.2011.12.004. No abstract available.

PMID:
22341177
5.

Transdermal hormone replacement therapy not associated with an increased risk of stroke.

Brown S.

Menopause Int. 2010 Jun;16(2):48-9. doi: 10.1258/mi.2010.010019. No abstract available.

PMID:
20729492
6.

Re: Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.

Pereira C, Castilho E.

Am J Epidemiol. 2009 Mar 15;169(6):783; author reply 783-4. doi: 10.1093/aje/kwp016. Epub 2009 Feb 10. No abstract available.

7.

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis.

Dören M.

Eur Heart J. 2009 Apr;30(7):866-7. doi: 10.1093/eurheartj/ehn618. Epub 2009 Jan 23. No abstract available.

8.

Letter to the Editor re: Linoleic acid and coronary heart disease. Prostaglandins Leukot. Essent. Fatty Acids (2008), by W.S. Harris.

Ramsden CE, Hibbeln JR, Lands WE.

Prostaglandins Leukot Essent Fatty Acids. 2009 Jan;80(1):77; author reply 77-8. doi: 10.1016/j.plefa.2008.12.002. Epub 2009 Jan 14. No abstract available.

PMID:
19147338
9.

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.

Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.

J Cardiovasc Med (Hagerstown). 2009 Jan;10(1):85-92. doi: 10.2459/JCM.0b013e328313e979.

PMID:
19145119
10.

HRT and cardiovascular disease.

Stevenson JC.

Best Pract Res Clin Obstet Gynaecol. 2009 Feb;23(1):109-20. doi: 10.1016/j.bpobgyn.2008.10.010. Epub 2008 Dec 17.

PMID:
19095500
11.

Hormone replacement therapy and thrombotic risk: beauty is only skin deep.

Rosendaal FR.

Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):684-5. doi: 10.1038/ncpcardio1346. Epub 2008 Sep 16.

PMID:
18797429
12.

Oral contraceptives, hormone therapy and cardiovascular risk.

Shapiro S.

Climacteric. 2008 Oct;11(5):355-63. doi: 10.1080/13697130802322848.

PMID:
18781479
13.

Postmenopausal hormone therapy and the risk of venous thromboembolism.

Rachoń D, Teede H.

Climacteric. 2008 Aug;11(4):273-9. doi: 10.1080/13697130802227724. Review.

PMID:
18645692
14.

Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials.

Mannucci E, Monami M, Lamanna C, Gensini GF, Marchionni N.

Diabetes Obes Metab. 2008 Dec;10(12):1221-38. doi: 10.1111/j.1463-1326.2008.00892.x. Epub 2008 May 26. Review.

PMID:
18505403
15.

Can menopausal hormone therapy prevent coronary heart disease?

Brinton EA, Hodis HN, Merriam GR, Harman SM, Naftolin F.

Trends Endocrinol Metab. 2008 Aug;19(6):206-12. doi: 10.1016/j.tem.2008.03.002. Epub 2008 Apr 29. Review.

PMID:
18450469
16.

Postmenopausal hormone use: what does the latest evidence show?

Theroux R.

Nurs Womens Health. 2008 Feb;12(1):56-61. doi: 10.1111/j.1751-486X.2007.00276.x. No abstract available.

PMID:
18257887
17.

[Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].

Gaspard U.

J Gynecol Obstet Biol Reprod (Paris). 2008 Jun;37(4):340-5. doi: 10.1016/j.jgyn.2007.12.003. Epub 2008 Feb 4. Review. French.

18.

Learning how to control biases in studies to identify adverse effects of drugs.

Vessey M.

J R Soc Med. 2007 Nov;100(11):526-7. No abstract available.

19.

Re: "invited commentary: Hormone therapy and risk of coronary heart disease-why renew the focus on the early years of menopause?".

Rosenberg L.

Am J Epidemiol. 2007 Dec 15;166(12):1480-1; author reply 1481-2. Epub 2007 Nov 10. No abstract available.

20.

Re: "invited commentary: Hormone therapy and risk of coronary heart disease--why renew the focus on the early years of menopause?".

Dören M, Greiser EM.

Am J Epidemiol. 2007 Dec 15;166(12):1479-80; author reply 1481-2. Epub 2007 Oct 31. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk